Result of 2022 Annual General Meeting

RNS Number : 2982D

Accrol Group Holdings PLC

18 October 2022

 

18 October 2022

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

Result of 2022 Annual General Meeting

Accrol, the leading independent tissue converter in the UK, announces that all of the resolutions set out in the Notice of AGM were passed by the requisite majority at the Company's AGM, held earlier today.

Details of the proxy votes received by the Company are as follows:

Resolution	For		Against		Withheld
	No. of votes	%	No. of votes	%	No. of votes
1.  To receive the Annual Report and Accounts	189,816,491	99.95	103,474	0.05	10,759
2.  To appoint BDO as Auditor	189,621,942	99.84	298,023	0.16	10,759
3.  To approve the Directors' Remuneration Report	179,946,678	94.75	9,973,287	5.25	10,759
4.  To re-elect Simon Allport as a Director	188,359,619	99.28	1,360,346	0.72	210,759
5.  To authorise the Directors to allot relevant securities	189,586,383	99.82	333,582	0.18	10,759
6.  To authorise the Directors to allot equity securities for cash without making a pre-emptive offer to shareholders*	189,585,650	99.82	334,315	0.18	10,759

*Special resolution

Notes:

1.	Proxy appointments which gave discretion to the Chairman of the AGM have been included in "For" total for the appropriate resolution.
2.	Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.
3.	A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".
4.	The number of shares in issue on 18 October 2022 was 318,878,097 with no shares in treasury.
5.	The full text of the resolutions passed at the AGM is available in the Notice of AGM on the Company's website: https://www.accrol.co.uk/app/uploads/2022/09/22-09-23-Accrol-Notice-of-AGM-Web-1.pdf.

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman	Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Richard Newman, Chief Financial Officer
Zeus (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton	Tel: [phone]
Dominic King	Tel: [phone]
Liberum Capital Limited (Joint Broker)	Tel: [phone]
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine	Tel: [phone]
Keeley Clarke	Tel: [phone]
	[e-mail]

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

For more information, please visit www.accrol.co.uk

 

END

 

 

RAGLVLFFLBLLFBE